ALD-309

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameALD-309
Drug Alias NameALD-309ALD-306
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionProprotein convertase subtilisin kexin type 9 inhibitors
TargetsProprotein convertase subtilisin kexin type 9
Therapy Area/IndicationsLipid Metabolism DisordersCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlder Biopharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlder Biopharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsLipid Metabolism DisordersCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A